Depression; Stomach issue; increase of lipase; bloating; constipation; Irregular heart rate; Memory loss; brain fog; Chest and stomach pain; Chest and stomach pain; Joint pain; Anxiety; Loss of energy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16-year-old male patient received BNT162b2 (BNT162B2), on 27Aug2021 at 15:00 as dose 2, single (Batch/Lot number: unknown) at the age of 15 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (Prev dose 1 product=COVID 19, Pfizer, administration date=06Aug2021), administration date: 06Aug2021, when the patient was 15-year-old, for Covid-19 immunization. The following information was reported: ANXIETY (hospitalization, disability) with onset 28Aug2021, outcome "not recovered"; CHEST PAIN (hospitalization, disability), ABDOMINAL PAIN UPPER (hospitalization, disability) all with onset 28Aug2021, outcome "not recovered" and all described as "Chest and stomach pain"; DEPRESSION (hospitalization, disability) with onset 28Aug2021, outcome "not recovered"; HEART RATE IRREGULAR (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "Irregular heart rate"; ARTHRALGIA (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "Joint pain"; ASTHENIA (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "Loss of energy"; AMNESIA (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "Memory loss"; ABDOMINAL DISCOMFORT (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "Stomach issue"; ABDOMINAL DISTENSION (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "bloating"; FEELING ABNORMAL (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "brain fog"; CONSTIPATION (hospitalization, disability) with onset 28Aug2021, outcome "not recovered"; LIPASE INCREASED (hospitalization, disability) with onset 28Aug2021, outcome "not recovered", described as "increase of lipase". The patient was hospitalized for depression, abdominal discomfort, lipase increased, abdominal distension, constipation, heart rate irregular, amnesia, feeling abnormal, chest pain, abdominal pain upper, arthralgia, anxiety, asthenia (hospitalization duration: 1 day(s)). The events "depression", "stomach issue", "increase of lipase", "bloating", "constipation", "irregular heart rate", "memory loss", "brain fog", "chest and stomach pain", "joint pain", "anxiety" and "loss of energy" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: (unspecified date) Negative; Heart rate: (28Aug2021) Irregular; Lipase: (28Aug2021) increase; SARS-CoV-2 test: (unspecified date) Negative; (unspecified date) Negative. It was unknown if therapeutic measures were taken as a result of depression, abdominal discomfort, lipase increased, abdominal distension, constipation, heart rate irregular, amnesia, feeling abnormal, chest pain, abdominal pain upper, arthralgia, anxiety, asthenia. Clinical course: The patient did not received any other vaccine prior to four weeks and did not receive any other medications prior to two weeks. The patient did not tested for covid prior vaccination. The patient tested to covid after post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.